NCT04826471View on ClinicalTrials.gov

Clinical Investigation on the Performance and Safety of DermoRelizema Ecofoam

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 13, 2021

Primary Completion Date

January 5, 2022

Study Completion Date

January 5, 2022

Conditions
Dermatitis
Interventions
DEVICE

DermoRelizema ecofoam

DermoRelizema ecofoam, class II a medical device, topical compact mousse, to be applied 2 times per day during the 42 days of study duration

Trial Locations (1)

80138

"Azienda Ospedaliero Universitaria Federico II", Napoli

All Listed Sponsors
lead

Relife S.r.l.

INDUSTRY